top of page
gradientForSurfBreak.png

Item List

May 3, 2022
PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

Portfolio Company

Carlsmed.png

Oscar Health (OSCR) Jumps 7.8% on New Menopause Plan, AI Tools ...

Yahoo Finance

Oct 22, 2025

Portfolio Company

Carlsmed.png

Elektra Health and Oscar Launch HelloMeno the First-Ever Menopause Health Plan i ...

PR Newswire

Oct 20, 2025

Portfolio Company

Carlsmed.png

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index ...

Yahoo Finance

Sep 22, 2025

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page